open-label duloxetine trials coming soon

Posted by jrbecker on February 26, 2003, at 13:19:12

see below or call 1-877-CTLILLY (1-877-285-4559)...
Open-Label Treatment with Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients with Major Depression
This study is not yet open for patient recruitment.
Sponsored by
Eli Lilly and Company
Purpose
The purposes of this study are to determine:
The safety of duloxetine and any side effects that might be associated with it.
Whether duloxetine can help patients with major depression.
The safety associated with switching from a medication you may be taking for depression to taking duloxetine.
It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed.
Condition Treatment or Intervention Phase
Major Depressive Disorder Drug: duloxetine Phase III
MEDLINEplus related topics: Mental Health
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 18 Years and above , Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
You must be at least 18 years old.
You must have been diagnosed with major depressive disorder.
You must be able to visit the doctor's office once a week to once every 2 weeks for a total of 14 weeks
Exclusion Criteria:
You are a woman and are pregnant or breastfeeding.
You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
You have had a primary diagnosis of an anxiety disorder within the past 6 months.
You have a history of alcohol or drug dependence or abuse within the past 6 months.
Location and Contact Information
Call Center 1-877-CTLILLY (1-877-285-4559)
California
Los Angeles, California, United States
Carisbad, California, United States
Stanford, California, United States
Connecticut
Cromwell, Connecticut, United States
Florida
Coral Springs, Florida, United States
Gainesville, Florida, United States
Miami, Florida, United States
Georgia
Atlanta, Georgia, United States
Maine
Bangor, Maine, United States
Massachusetts
Boston, Massachusetts, United States
New York
Rochester, New York, United States
New York, New York, United States
Ohio
Cincinnati, Ohio, United States
Pennsylvania
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Texas
Dallas, Texas, United States
Houston, Texas, United States
San Antonio, Texas, United States
Virginia
Falls Church, Virginia, United States
Richmond, Virginia, United States
Charlottesville, Virginia, United States
Washington
Seattle, Washington, United States
Wisconsin
West Allis, Wisconsin, United States
More Information
Study ID Numbers 6476
Study Start Date December 2002; Estimated Completion Date December 2003
Record last reviewed August 2002
NLM Identifier NCT00042562
ClinicalTrials.gov processed this record on 2003-02-26

Thread

open-label duloxetine trials coming soon jrbecker 2/26/03
Well, I guess we can keep waiting for it. . . . Jack Smith 2/26/03
trials coming soon--NOT SOON, already started. Jack Smith 2/26/03
Re: just called Lilly - it has NOT started yet jrbecker 2/26/03
My apologies Jack Smith 2/26/03
Re: duloxetine trials jrbecker 2/26/03

Post a new follow-up

Notify the administrators

Start a new thread

poster:jrbecker thread:204032
URL: http://www.dr-bob.org/babble/20030224/msgs/204032.html